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Introduction: Pulmonary function is compromised in most smokers. Yet it is unknown whether exercise
training improves pulmonary function and aerobic capacity in cigarette and hookah smokers and whether
these smokers respond in a similar way as do non-smokers.
Aim: To evaluate the effects of an interval exercise training program on pulmonary function and aerobic
capacity in cigarette and hookah smokers.
Methods: Twelve cigarette smokers, 10 hookah smokers, and 11 non-smokers participated in our exercise
program. All subjects performed 30 min of interval exercise (2 min of work followed by 1 min of rest) three
times a week for 12 weeks at an intensity estimated at 70% of the subject’s maximum aerobic capacity
(V

O2max). Pulmonary function was measured using spirometry, and maximum aerobic capacity was assessed
by maximal exercise testing on a treadmill before the beginning and at the end of the exercise training program.
Results: As expected, prior to the exercise intervention, the cigarette and hookah smokers had significantly
lower pulmonary function than the non-smokers. The 12-week exercise training program did not significantly
affect lung function as assessed by spirometry in the non-smoker group. However, it significantly increased
both forced expiratory volume in 1 second and peak expiratory flow (PEF) in the cigarette smoker group, and
PEF in the hookah smoker group. Our training program had its most notable impact on the cardiopulmonary
system of smokers. In the non-smoker and cigarette smoker groups, the training program significantly im-
proved V

O2max (4.4 and 4.7%, respectively), v V

O2max (6.7 and 5.6%, respectively), and the recovery index
(7.9 and 10.5%, respectively).
Conclusions: After 12 weeks of interval training program, the increase of V

O2max and the decrease of
recovery index and resting heart rate in the smoking subjects indicated better exercise tolerance. Although the
intermittent training program altered pulmonary function only partially, both aerobic capacity and life
quality were improved. Intermittent training should be advised in the clinical setting for subjects with adverse
health behaviors.
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E
xamining the relationship of smoking habits, res-
piratory symptoms and lung function to mortality
in men from the general population aged 5060
years, Olofson et al. (1) demonstrated that the mortality
rate was significantly related to age, smoking habits, and
dyspnea. Furthermore, these authors showed that impaired
lung function is an important factor to be considered
in the assessment of mortality risk, besides smoking and
dyspnea.
Smoking is one of the most important risk factors
for future cardiovascular morbidity and a major cause
of cardiovascular disease mortality (2). It has significant
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detrimental effects on both the structure and function
of the lung; it is the single most important risk factor for
the development of chronic obstructive pulmonary dis-
ease (COPD) (3). Studies have documented lower forced
expiratory volume in 1 second (FEV1), accelerated loss of
ventilatory function, and increased respiratory symptoms
among smokers compared with non-smokers (4). Data
from other studies have consistently shown increased
mortality from COPD, and pneumonia among cigarette
smokers compared with non-smokers (5). Smokers had
double the mortality rate of non-smokers (1). According
to Higgins et al., the prevalence of chronic bronchitis was
higher and mean FEV1 was lower in cigarette smokers
than non-smokers, and heavy smokers were affected more
than light smokers (6). Likewise, the results reported by
Mohammad et al. showed a higher proportion of chronic
bronchitis and a quasi-permanent alteration in maxi-
mum mid-expiratory flow (MMEF 2575%) in narguileh
smokers compared with cigarette smokers. These authors
added that FEV1 was more altered in cigarette smokers
than in narguileh smokers (7).
Physical training can enhance health in many ways. It
has been shown to improve cardiovascular performance
(8, 9), to prevent premature death (10), and to promote
longevity (11, 12). In previous studies, regular exercise
training has been related to better pulmonary function
(13, 14). Also other studies report a positive association
between physical activity and physical fitness and lung
capacity (15, 16), while others do not (17).
The V

O2max components, heart rate (HR) and systolic
blood pressure (SBP), are important indicators of cardi-
ovascular health and fitness. Lower HR at rest and during
exercise is associated with improved physical fitness (1820).
Higher values of HR and SBP at rest, as well as their
increased variability and response during exercise, are im-
portant risk factors and prognostic indicators of cardio-
vascular disease mortality (21, 22). Smokers usually exhibit
elevated HR and reduced exercise capacity and, thus,
lower overall cardiovascular fitness (23, 24).
The benefit of training programs appears to be impor-
tant in the general healthy population for increasing car-
diorespiratory performance (25). The practice of physical
activity is associated with an increase in V

O2max regard-
less of age (26, 27). Moreover, several studies examining
the effects of physical training on BP, HR, and V

O2max
in healthy adults have yielded convincing results (12, 28, 29).
Most studies on the effects of physical activity on res-
piratory and cardiovascular functions focused on special
populations, such as athletes or patients with COPD
(30, 31). However, it is not known whether intermittent
physical training can retard the deterioration of pulmonary
function and improve cardiorespiratory fitness in smokers
unwilling or unable to quit.
Investigating the relationship between physical activity
and cardiovascular and respiratory functions of smokers
will aid in understanding the mechanisms of how physical
activity improves quality of life. The major purpose of this
study was to examine the effects of 12 weeks of inter-
mittent training on pulmonary function among sedentary
cigarette smokers versus hookah smokers. We also evalua-




A total of 35 sedentary smokers and non-smokers with
the following average characteristics9standard devia-
tion (SD) participated in this study: age, 44.794.5 years;
weight, 71.392.7 kg; height, 174.392.3 cm.
After receiving a complete verbal description of pro-
tocol, risks and benefits of the study, each subject signed
a written consent. This study was approved by the Faculty
of Medicine Ethical Research Committee, University of
Sfax, Tunisia.
We excluded people who had any self-reported physician-
diagnosed chronic disease (arthritis, diabetes, hypertension,
cancer, heart attack, chronic cough, bronchitis, abnormal
exercise electrocardiogram, or FEV1/FVC%B70%) (32, 33)
at the visit before protocol.
Cigarette and hookah smokers unable or unwilling to
quit were recruited according to the number of cigarettes
and hookahs per day and how long they have been
smoking. We considered cigarette smokers all subjects
with consumption greater or equal to 10 pack-years (PY)
and an average score of tobacco dependence of 7.339
1.67, measured by the Fagerström nicotine dependence
test (34). In the absence of specific international codifica-
tion, we quantified hookah consumption, as in the study
of Kiter et al. (35), in hookah-years (HY) and kilogram
of cumulative tobacco. The tobacco used in a single
hookah session weighs between 10 and 25 g (36). Regular
hookah smokers are those having tobacco consumption
greater or equal to 5 HY (37).
Participants were divided into three groups: a cigarette
smoker group (CS) (n11), a hookah smoker group
(HS) (n12), and a non-smoker group (NS) (n12).
Pulmonary function assessment
Spirometry assessments were undertaken in accordance
with standards described by the American Thoracic
Society (38). Standard procedure requires forced vital
capacity (FVC) and FEV1 to be measured from a series of
at least three forced expiratory curves (39). Consequently,
this study required participants to perform three correct
manoeuvres. Participants completed the spirometry assess-
ment seated, using a portable spirometer (MIR Spirobank
G USB Spirometer, Rome, Italy), with a nose clip attached.
Pulmonary function variables included FVC, FEV1, and
FEV1/FVC ratio. Results were expressed as percentages
Abdessalem Koubaa et al.
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of the predicted value to allow comparison of results
across participants.
Aerobic capacity assessment
Exercise tolerance, achieved during a maximal treadmill
exercise test, is a leading indicator of circulatory system
capacity as it is strongly related to maximum oxygen
uptake (V

O2max) (40). All the participants underwent
a progressive exercise test performed on a treadmill
(Pulmonary Function Equipment, COSMED, Rome, Italy)
in the research unit of the Higher Institute of Sport and
Physical Education of Sfax. The test began with a warm-
up at a speed of 6 km/h for 5 min, after which the speed
was increased incrementally by 1 km/h every 2 min until
exhaustion. HR was monitored throughout the test using
Polar Electro Oy (Kempele, Finland) and was recorded at
the conclusion of every 2-min stage. Verbal encourage-
ment was provided throughout the test to ensure that the
maximal effort was achieved. During the exercise test,
oxygen consumption was continually recorded using an
oxygen analyzer (Fitmate, version 1.2 PRO COSMED).
Oxygen consumption (VO2) during the exercise test was
measured in real time by means of a dynamic mixing
chamber, and data were recorded every 2 min. At the end
of the test, a detailed report was printed.
Exercise program
All training sessions were completed at the Higher
Institute of Sport and Physical Education of Sfax under
supervision of qualified specialist trainers. Subjects in the
three groups underwent an intermittent training program
that consisted of three sessions per week for approxima-
tely 30 min per session, during a 12-week period. The inten-
sity of the exercise was controlled by time and distance
travelled. All warm-ups before training were between
50 and 60% of maximum HR for a period of about 10 min.
The intermittent training consisted of 30 min of work/
rest. Participants were instructed to run for 2 min at an
intensity workload that equated to 70% of their individual
v V

O2max, interspersed with recovery periods of 1 min.
This sequence was repeated 10 times during the 30-min
period. Exercise intensity was gradually increased every
2 weeks over the course of the training period, based on
the ability of each participant.
Statistical analysis
All statistical tests were processed using STATISTICA
Software (StatSoft, France). The data are expressed as
mean9SD. Analysis of variance (ANOVA) was carried
out to compare the responses of the different groups
before and after the training program. Least significant
difference (LSD) post-hoc analysis was used to identify
significant group differences that were indicated by
ANOVA. A probability level of 0.05 was selected as the
criterion for statistical significance.
Results
Before training, we did not observe any significant differ-
ence in basal cardiorespiratory values between the non-
smoker group and the smoker groups. The (D) results
of the maximal exercise tests after training are presented
in Table 1. At the end of the training program, the par-
ticipants showed similar improvements. However, no signi-
ficant differences were found among the three groups.
After the training program, a small but significant decrease
(pB0.05) in the resting HR was observed in each of the
three groups (394, 393, and 294 for NS, CS, and HS,
respectively). Similarly, there was a decrease of 293
(mm Hg) in systolic BP for each of the three groups. The
decrease in the diastolic BP was significant only in the
CS group.
At maximal exercise, there was an increase of 6.7 and
5.6% in v V

O2max, an increase of 4.4 and 4.7% in V

O2max,
and an increase of 7.9 and 10.5% in the Recovery Index
for NS and CS groups, respectively. However, for none
of these parameters was there a statistically significant
change for the HS group (Fig. 1).
We observed significant differences in baseline spiro-
metric values when the three groups were compared
(Table 2). Smoking cigarettes or hookah resulted in lower
Table 1. Improvement rate (D) of cardio-respiratory values in subjects of the three groups (NS, CS, and HS)
Mean9SD Pre vs. Post
Parameters NS CS HS NS CS HS
Resting HR (bpm) 394 393 294 $ $ $
Systolic BP (mm Hg) 293 293 292 $ $$ $
Diastolic BP (mm Hg) 294 395 293 ns $ ns
v V





O2max (ml min kg
1) 1.793.3 1.892.6 1.592.1 $ $ ns
Recovery index 1.291.3 1.692.5 0.991.5 $ $$ ns
NS: non-smokers; CS: cigarettes smokers; HS: hookah smokers; V

O2max: maximum oxygen uptake; v V

O2max: velocity at maximum
oxygen uptake; HR: heart rate; bpm: beats per minute; BP: blood pressure.
$, $$: significant difference Pre- vs. Post program at pB0.05, pB0.01, respectively.
Training effects on lung function and aerobic capacity of smokers
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values of FEV1 and peak expiratory flow (PEF) (pB
0.001) compared with the non-smokers, but smoking did
not influence the FEV1/FVC ratios (p0.362). By con-
trast, forced expiratory flow (FEF50%) and FEF2575%
values were lower in the smokers compared to the non-
smokers (pB0.001 and p0.004, respectively).
Changes (D) in the spirometric values are presented in
Table 3. After training, most variables showed a small,
positive D that did not reach statistical significance.
However, significant increases in PEF rate of 3.8 and
3.4% were detected for both CS and HS groups (pB0.01
and pB0.05, respectively), while a significant FEV1 change
was observed in the CS group only.
As shown in Fig. 2, a significant increase in FEV1
(6.2%) was observed in the SC group (pB0.05). No signifi-
cant FEV1 changes were observed for the other two groups.
Furthermore, the training program did not result in
any significant changes in any of the three groups with
respect to FVC and FEF.
Discussion
Physical inactivity and low cardiorespiratory fitness are
recognized as important causes of morbidity and mor-
tality (4143). The data presented in this study showed
the relation between physical activity in the form of inter-
mittent exercise and cardiorespiratory function for male
smokers and non-smokers. In a longitudinal study of
Norwegian men (44), the authors concluded that decline
in physical fitness and lung function among healthy
middle-aged men was considerably greater among smokers
than non-smokers. Smoking is the most important modi-
fiable risk factor for decreased respiratory function (16, 45).
This study was designed to measure the effects of an
intermittent training program on lung function and
aerobic capacity in adult smokers. Initially, the mean
spirometric values of smokers were lower than those of
non-smokers. After 12 weeks of training, the mean spiro-
metric values at rest were slightly higher, without a signi-
ficant difference, except for FEV1 and PEF for the CS
Fig. 1. Intra-group changes in percentage (D %) of cardio-respiratory parameters of the three groups.
Table 2. Spirometric data of the three groups before the training protocol
Mean9SD
Parameters NS CS HS ANOVA
FVC (%) 100.595.8 95.594.5 93.197.9** p0.018
FEV1 (%) 103.395 94.196.5*** 95.396.6** pB0.001
PEF (%) 110.395.2 102.596.7** 10194.3*** pB0.001
Tiffeneau index (%) 1.0390.07 0.9990.06 1.0390.11 p0.362
FEF2575% (%) 103.3910.1 94.995** 93.994.4** p0.004
FEF50% (%) 99.894.5 94.792.6** 9393.8*** pB0.001
NS: non-smokers; CS: cigarettes smokers; HS: hookah smokers; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 second;
PEF: peak expiratory flow; FEF50%: forced expiratory flow at 50% of FVC; FEF2575%: forced expiratory flow at 2575% of FVC.
**, ***: significant difference compared with non-smokers at pB0.01, pB0.001, respectively.
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4
(page number not for citation purpose)
Citation: Libyan J Med 2015, 10: 26680 - http://dx.doi.org/10.3402/ljm.v10.26680
and HS groups. Pulmonary functions parameters were
improved to a greater extent in most participants of the
smoker groups than the non-smoker group. The most
significant improvements occurred in FEV1 and PEF
in the two smoker groups. These results are in line with
those of Miles (46) and Gass et al. (47). The improvement
in PEF was significantly slower among hookah smokers
compared to cigarette smokers. In contrast, we did not
observe any effect of the 12 weeks of training on FVC or
FEF. In the light of these results, we believe that training
programs of this duration have only minor effects on spiro-
metric variables.
Our study shows that interval training of more than
three times per week reduces the decline in pulmonary
function. The beneficial effect of physical activity on pul-
monary function was independent of smoking and was
almost similar for the two smoking methods.
It has also been claimed that physical activity is posi-
tively associated with pulmonary function (13, 46, 48)
and can enhance inspiratory muscle endurance (49). Inter-
estingly, using a short-term training protocol, Biersteker
et al. (17) did not observe any effect of physical train-
ing on physical fitness and lung vital capacity in young
adults.
In the present study, the non-smokers group showed
no significant change in lung function as a result of the
training program. By contrast, the two groups of smokers
saw their respiratory ability improve significantly due to
training, a result that is consistent with several previous
studies (50, 51). Therefore, this study provides objective
data supporting the use of a program of intermittent
exercise for strengthening the pulmonary functions of
smokers.
A number of benefits of intermittent training have been
previously demonstrated. This training program slows
the decline in pulmonary function and alleviates symp-
toms and exacerbation of pulmonary disease, resulting in
improvement of quality of life. Our study suggests that
Table 3. Improvement rate (D) of respiratory parameters in subjects of the three groups (NS, CS, and HS)
Mean9SD Pre vs. Post
Parameters NS CS HS NS CS HS
FVC (%) 1.998.8 4.499.6 3.699 ns ns ns
FEV1 (%) 0.597.8 5.899.2 496.4 ns
$ ns
PEF (%) 1.495.8 3.993.8** 3.493.9* ns $$ $
Tiffeneau index (%) 0.0190.13 0.0290.10 0.00190.08 ns ns ns
FEF2575% (%) 2.294.4 1.896.6 2.395.8 ns ns ns
FEF50% (%) 0.594.1 0.893.5 0.995.2 ns ns ns
NS: non-smokers; CS: cigarettes smokers; HS: hookah smokers; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 second;
PEF: peak expiratory flow; FEF50%: forced expiratory flow at 50% of FVC; FEF2575%: forced expiratory flow at 2575% of FVC.
*, **: significant difference compared with non-smokers at pB0.05, pB0.01, respectively; $, $$: significant difference pre- vs. postprogram
at pB0.05, pB0.01, respectively.
Fig. 2. Intra-group changes in percentage (D %) of spirometric values of the three groups.
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interval exercise training may be useful in slowing the pro-
gression of pulmonary disease due to cigarette smoking.
It is generally accepted that people with higher levels
of physical activity tend to have higher levels of fitness
and that physical activity can improve cardiorespira-
tory fitness (52). In our study, intermittent exercises were
strongly associated with better exercise tolerance assessed
with maximal treadmill test, a finding consistent with
other studies (42, 53).
In accordance with the literature (5457), our training





O2max, and RI for the two smoker groups. Those
results are somewhat similar to those reported by Leon
et al. (18), who used the same kind of treadmill test to assess
physical capacity of participants. The changes in resting
HR, systolic BP, and diastolic BP were also significant.
These results demonstrate the efficacy of our intermittent
training program in smokers and non-smokers.
In summary, the interval training program used in the
present study significantly improved exercise performance
and symptoms for both groups of smokers. These conclu-
sions are consistent with the results of several published
studies, which indicated that exercise is an important com-
ponent of pulmonary rehabilitation and may be associa-
ted with both physiological and psychological benefits (19).
Although smoking cessation is certainly an impor-
tant way to reduce the decline in pulmonary function in
smokers, this training method appears to be beneficial in
both smokers and non-smokers and can be performed by
all individuals. Interval training was related to a slower
decline in pulmonary function due to smoking.
Because the exercise intensity was adapted to parti-
cipant capacity, our intermittent training program is a
suitable method for improving ventilatory efficiency. Our
findings are potentially important from both the public
health and the clinical points of view.
Because passive smoking causes lung function decline,
and based on previous findings of Mohammad et al. (58),
we think that future research should include a group of
passive smokers. Other studies using other training methods
will be needed to advance our conclusions. We believe
that the continuous exercise training programs could im-
prove the aerobic capacity and modify more favorably the
lung function of smokers.
Conclusions
Our intermittent training program improved the aerobic
capacity and modified the cardiorespiratory parameters
of smokers in a way that approximates those of non-
smokers. After 12 weeks of training, V

O2max and recovery
index were improved, and there was a significant decrease
in resting HR. These results demonstrate the benefi-
cial effects of intermittent training on the cardiopulmo-
nary system and quality of life even in the smoking
population.
Limitations of the study
The lack of a control group may be considered a limita-
tion of the present study (smokers following their usual
daily activity during the protocol period). Also, the rela-
tively small sample size could have limited our ability
to detect group differences in the chosen parameters.
This is indeed a limitation of this work, and should be
considered relative to our findings.
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